Do T1a breast cancers profit from adjuvant systemic...

Do T1a breast cancers profit from adjuvant systemic therapy? A multicenter retrospective cohort study of 325 T1a-patients

Wolters, R., Ebner, F., Janni, W., Novopashenny, I., Wöckel, A., Kreienberg, R., Wischnewsky, M., Schwentner, Lukas
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
294
Language:
english
Journal:
Archives of Gynecology and Obstetrics
DOI:
10.1007/s00404-016-4016-y
Date:
August, 2016
File:
PDF, 1.12 MB
english, 2016
Conversion to is in progress
Conversion to is failed